MedTrace Logo

Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers

NCT05359042 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-05-08

No results posted yet for this study

Summary

This is a randomized trial of patients with gastrointestinal (GI) cancers treated at University of California, San Francisco (UCSF) who are starting a new line of systemic therapy to evaluate the feasibility of electronic patient reported outcome (ePRO) platform.

Conditions

Interventions

OTHER

Electronic Patient Reported Outcomes platform

The ePRO tool is developed by a third-party vendor, Conversa, and engages the patient in a chat-based interaction to assess patient symptoms and provide educational material.

OTHER

Health Related Quality of Life Surveys

Surveys will be administered to participants

Sponsors & Collaborators

Principal Investigators

  • Wesley A Kidder, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-15
Primary Completion
2024-12-30
Completion
2024-12-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05359042 on ClinicalTrials.gov